Patent Number: 7,087,647

Title: Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue

Abstract: Modafinil is effective in improving symptoms of attention deficit hyperactivity disorder and symptoms of multiple sclerosis fatigue. The administration of modafinil is also shown to activate the tuberomamillary neurons of the posterior hypothalamus, and thus exhibits activity in an area of the brain associated with normal wakefulness functions.

Inventors: Miller; Matthew S. (Newtown, PA), Scammell; Thomas E. (Wellesley, MA)

Assignee: Cephalon, Inc.

International Classification: A61K 31/165 (20060101)

Expiration Date: 8/08/02018